A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

Clinical trial NCT06063681 · RECRUITING

Trial details

NCT number: NCT06063681
Sponsor: Stingray Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced / Metastatic Solid Tumor

Start date: 2023-10-12
Primary completion: 2025-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.